Asthma & COPD Market Volume Analysis, Segments, Value Share and Key Trends
Asthma is one of the most common diseases afflicting the world's population, as well as a life-threatening condition that affects a patient's regular breathing. It is a chronic condition that causes breathlessness, bronchospasm, and reversible obstruction of airflow by stretching and narrowing the lungs' air passages. "Smoker’s cough" or a chronic cough and breathlessness, Chronic Obstructive Pulmonary Disease (COPD) is defined by a persistent blockage of airflow in the lungs, resulting in abnormal sputum. Cough, breathlessness (shortness of breath) and wheezing, sputum, chest infections, weight loss, tiredness, and ankle swelling are all symptoms of COPD. In 2020, global asthma and COPD market is expected to be worth US$ 30,710.2 million, and by 2027, it is expected to be worth US$ 42,608 million. Future growth in the anti-asthmatics and COPD drugs market will be driven by the increased popularity of e-cigarettes/vaping, rising obesity levels, technology, ...